Introduction mental health conditions and certain gastrointestinal or nausea-related conditions. However, in some cases, long-term use of certain medicines can lead to involuntary movements that are difficult to control. This condition is known as tardive dyskinesia (TD). 1,3 TD can affect daily functioning, communication, social interactions and quality of life. Fortunately, treatment options are available. Valbenazine is a VMAT2 inhibitor approved for the treatment of tardive dyskinesia and has been shown to reduce TD movements. 1,3 This article explains what tardive dyskinesia is, why it happens, and how valbenazine may help. Why Can Long-Term Medicines Cause Uncontrolled Movements? Certain medications, particularly those that affect dopamine signaling in the brain, may increase the risk of developing tardive dyskinesia when used for extended periods. 4,5,7 These medications commonly include 4,5,7 : Antipsychotic medicines Some medicati...
Introduction Choosing a treatment for lymphoma is not just about medical outcomes. It is also about time, access, readiness, and what is realistically possible for a patient and their family. With newer therapies entering the picture, patients are often faced with options that sound promising but feel difficult to compare. This piece looks at two such treatments and explores how they differ when it comes to access and availability, helping patients and caregivers think through what each option may mean in real life. Overview of Columvi and How It Works Columvi ( glofitamab gxbm ) is a prescription medication used to treat adults with certain types of large B cell lymphoma, including diffuse large B cell lymphoma, whose disease has returned or did not respond to earlier treatments, after they have already received two or more prior cancer therapies. 1 Columvi is a bispecific monoclonal antibody, which means it is designed to attach to two...